Page last updated: 2024-10-22

amifostine anhydrous and Microsatellite Instability

amifostine anhydrous has been researched along with Microsatellite Instability in 1 studies

Amifostine: A phosphorothioate proposed as a radiation-protective agent. It causes splenic vasodilation and may block autonomic ganglia.
amifostine : An organic thiophosphate that is the S-phospho derivative of 2-[(3-aminopropyl)amino]ethanethiol. A prodrug for the free thiol, WR-1065, which is used as a cytoprotectant in cancer chemotherapy and radiotherapy.

Microsatellite Instability: The occurrence of highly polymorphic mono- and dinucleotide MICROSATELLITE REPEATS in somatic cells. It is a form of genome instability associated with defects in DNA MISMATCH REPAIR.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Pinto, JL1
Fonseca, FL1
Marsicano, SR1
Delgado, PO1
Sant'anna, AV1
Coelho, PG1
Maeda, P1
Del Giglio, A1

Trials

1 trial available for amifostine anhydrous and Microsatellite Instability

ArticleYear
Systemic chemotherapy-induced microsatellite instability in the mononuclear cell fraction of women with breast cancer can be reproduced in vitro and abrogated by amifostine.
    The Journal of pharmacy and pharmacology, 2010, Volume: 62, Issue:7

    Topics: Amifostine; Antimutagenic Agents; Antineoplastic Agents, Alkylating; Breast Neoplasms; Cell Line, Tu

2010